As per the research report, the size of the Europe Cell Signaling Market is valued at USD 1.05 billion in 2019 and is relied upon to reach USD 0.77 billion by 2024 to grow at 6.30% CAGR during the forecast period 2019 to 2024.
Growth in the cell signaling market is mainly driven by the rise in the incidence of chronic diseases, availability of funds for cell-based research, technological advancements in cell-based research instruments, and the development of the life science and biopharmaceutical industries.
Cell signaling is used to study signal paths of cells in drug discovery and therapeutic development, to distinguish drug resistance patterns in cancerous cells. It also identifies the major signaling paths impacted by specific drug treatments. Cell signal paths also are known as signal transduction paths act as a bridge between environmental stimuli and the corresponding cellular response. These signal paths are primarily made up of proteins that can interact, move to specific locations, or be modified.
Growth in the medical supplies market is mainly driven by a rise in the incidence of chronic diseases and the availability of funds for cell-based research activities. Moreover, factors such as technological advancements in cell-based research instruments and growth in life science and biopharmaceutical industries are expected to aid the growth of the market. However, moral issues related to embryonic stem cell signaling research and the expensive cell signaling systems are expected to hinder the growth of this market. Growth in this regional segment is mainly driven by the growth in the geriatric population, rise in the instances of chronic diseases, and improved life science research infrastructure in the region.
This research report segmented and sub-segmented into the following categories:
Europe holds the second-largest share in the global market. Technological developments in developed economies like Germany are investing heavily in the research and development of cell signaling. Furthermore, favorable government policies are further expected to aid the growth of the market.
Key players operating in the Europe Cell Signaling Market profiled in this report are Merck KGaA, Becton, Dickinson and Company, Beckman Coulter, Inc., Thermo Fisher Scientific Inc., Bio-Rad Laboratories Inc., QIAGEN N.V., PerkinElmer Inc., Promega Corporation, Bio-Techne Corporation, Cell Signaling Technology, Inc., Abcam plc, Miltenyi Biotec, Cell Biolabs Inc., Full Moon BioSystems, Cisbio Bioassays, BioVision, Rockland Immunochemicals Inc., Tonbo Biosciences, StressMarq Biosciences Inc., BPS Bioscience, Abeomics Inc., RayBiotech, MEDICAL & BIOLOGICAL LABORATORIES CO, Sino Biological and Santa Cruz Biotechnology.
1.Introduction
1.1 Market Definition
1.2 Study Deliverables
1.3 Base Currency, Base Year and Forecast Periods
1.4 General Study Assumptions
2. Research Methodology
2.1 Introduction
2.2 Research Phases
2.2.1 Secondary Research
2.2.2 Primary Research
2.2.3 Econometric Modelling
2.2.4 Expert Validation
2.3 Analysis Design
2.4 Study Timeline
3. Overview
3.1 Executive Summary
3.2 Key Inferences
3.3 Epidemology
4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)
4.1 Market Drivers
4.2 Market Restraints
4.3 Key Challenges
4.4 Current Opportunities in the Market
5. Market Segmentation
5.1 Product
5.1.1 Introduction
5.1.2 Consumables
5.1.2.1 Antibodies
5.1.2.2 Reagents
5.1.2.3 Assay Kits
5.1.2.4 Others
5.1.3 Instruments
5.1.4 Y-o-Y Growth Analysis, By Product
5.1.5 Market Attractiveness Analysis, By Product
5.1.6 Market Share Analysis, By Product
5.2 Type
5.2.1 Introduction
5.2.2 Endocrine
5.2.3 Paracrine
5.2.4 Y-o-Y Growth Analysis, By Type
5.2.5 Market Attractiveness Analysis, By Type
5.2.6 Market Share Analysis, By Type
5.3 Application
5.3.1 Introduction
5.3.2 Research
5.3.3 Cancer
5.3.4 Immunology
5.3.5 Y-o-Y Growth Analysis, By Application
5.3.6 Market Attractiveness Analysis, By Application
5.3.7 Market Share Analysis, By Application
5.4 Pathway
5.4.1 Introduction
5.4.2 Akt
5.4.3 AMPK
5.4.4 Hedgehog
5.4.5 Notch
5.4.7 Y-o-Y Growth Analysis, By Pathway
5.4.8 Market Attractiveness Analysis, By Pathway
5.4.9 Market Share Analysis, By Pathway
5.5 Technology
5.5.1 Flow Cytometry
5.5.2 ELISA
5.5.3 Mass Spectrometry
6. Geographical Analysis
6.1 Introduction
6.1.1 Regional Trends
6.1.2 Impact Analysis
6.1.3 Y-o-Y Growth Analysis
6.1.3.1 By Geographical Area
6.1.3.2 By Product
6.1.3.3 By Type
6.1.3.4 By Application
6.1.3.5 By Pathway
6.1.3.6 By Technology
6.1.4 Market Attractiveness Analysis
6.1.4.1 By Geographical Area
6.1.4.2 By Product
6.1.4.3 By Type
6.1.4.4 By Application
6.1.4.5 By Pathway
6.1.4.6 By Technology
6.1.5 Market Share Analysis
6.1.5.1 By Geographical Area
6.1.5.2 By Product
6.1.5.3 By Type
6.1.5.4 By Pathway
6.1.5.5 By Indication
6.1.5.6 By Technology
6.2 U.K
6.3 Spain
6.4 Germany
6.5 Italy
6.6 France
7.Strategic Analysis
7.1 PESTLE analysis
7.1.1 Political
7.1.2 Economic
7.1.3 Social
7.1.4 Technological
7.1.5 Legal
7.1.6 Environmental
7.2 Porter’s Five analysis
7.2.1 Bargaining Power of Suppliers
7.2.2 Bargaining Power of Consumers
7.2.3 Threat of New Entrants
7.2.4 Threat of Substitute Products and Services
7.2.5 Competitive Rivalry within the Industry
8.Market Leaders' Analysis
8.1 Merck KGaA
8.1.1 Overview
8.1.2 Product Analysis
8.1.3 Financial analysis
8.1.4 Recent Developments
8.1.5 SWOT analysis
8.1.6 Analyst View
8.2 Becton
8.3 Dickinson and Company
8.4 Beckman Coulter Inc.
8.5 Thermo Fisher Scientific Inc.
8.6 Bio-Rad Laboratories Inc.
8.7 QIAGEN N.V.
8.8 PerkinElmer Inc.
8.9 Promega Corporation
8.10 Bio-Techne Corporation
9.Competitive Landscape
9.1 Market share analysis
9.2 Merger and Acquisition Analysis
9.3 Agreements, collaborations and Joint Ventures
9.4 New Product Launches
10.Market Outlook and Investment Opportunities
Appendix
a) List of Tables
b) List of Figures
Related Reports
